Answers are grounded in this paper and cite their sources.
Short chain fatty acids (SCFA) have multiple in vivo and in vitro effects including cell cycle arrest and induction of protein synthesis, differentiation, and apoptosis. Butyrate or derivatives have promise for treating inflammatory bowel disease and colon cancer. Genomic and proteomic analysis have generated new knowledge on function and applications for SCFA.
No takes yet. Share an insight, caveat, or question.
Steven J. Miller (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: